Commentaries: Quickly reporting cancer complications may boost survival – STAT News (free) AND If This Were a Drug, the Price Would Be $100,000 – Medscape (free registration required) AND How a simple tech tool can help cancer patients live longer – The Washington Post (free)
“For surveillance of cancer, digital tracking of patient-generated data improves survival”. “The cost of digital tracking is very low and > 5 months median survival improvement is more than cancer drugs that cost > $100,000” (RT @EricTopol see Tweets and Answers)
2 – #ASCO2017 – Abiraterone for Prostate Cancer
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer – New England Journal of Medicine (free) AND Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy – New England Journal of Medicine (free)
3 – Perspectives: Changing the narratives for patient safety – World Health Organization (free)
News release: How to Effectively Engage Patients in Patient Safety: New Guide available (free)
See also: How scientists reacted to the US leaving the Paris climate agreement – Nature News (free) Leaving the Paris Climate Accord Could Lead to a Public Health Disaster – Scientific American (free)
Related guideline: Climate Change and Health: A Position Paper of the American College of Physicians (free)
See more on Climate Change and Health in our April 21 issue, see #6, #7, #8 and #9.
7 – Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015 – The Lancet Infectious Diseases (free)
Invited commentary: Diarrhoeal disease trends in the GBD 2015 study: optimism tempered by skepticism (free)
Other commentaries: Despite substantial global reduction in diarrhea deaths, half a million children still die from diseases each year – Institute for Health Metrics and Evaluation (IHME) (free) AND Global diarrhoea deaths down by a third – BBC News (free)
“CAS and CEA were associated with similar rates of a composite of periprocedural death, stroke, MI, or nonperiprocedural ipsilateral stroke. The risk of long-term overall stroke was significantly higher with CAS, and was mostly attributed to periprocedural minor stroke”.